Authors



Allison Mathews, PhD

Latest:

Crowdsourcing Brings Researchers and the Community Together to Cure HIV

Misinformation about clinical research, mistrust between scientists and the community, and HIV-related stigma often impede efforts to find an HIV cure.



Paul Roemer

Latest:

What Can Your EHR Do for Me?

Before purchasing an EHR, physicians need to make sure it will deliver a return on investment, and that means asking some tough questions, says guest blogger Paul Roemer.


Rami N. Khouzam, MD

Latest:

Late diagnosis of a congenital coronary anomaly

A 64-year-old woman with a history of atrial fibrillation, hypertension, and sarcoidosis presented to the emergency department with chest pain. After a positive stress test, a coronary angiogram was performed, which showed normal coronary arteries except for an anomalous take-off of the left circumflex artery from the right coronary cusp.


P. Michael Ho, MD, PhD1-3

Latest:

Medication nonadherence and adverse outcomes in CAD patients

Nonadherence to beta blockers, statins, or angiotensin-converting enzyme inhibitors is common (21%-29%) among patients with coronary artery disease (CAD). Patients who do not adhere to their medication regimens are at increased risk of mortality, cardiovascular hospitalizations, and revascularization procedures; thus, medication nonadherence should be a target for quality improvement interventions to maximize the outcomes of CAD patients.


Jenna Dvorin

Latest:

Upadacitinib Better than Adalimumab in Rheumatoid Arthritis

A new study of AbbVie’s original JAK1-selective inhibitor indicates that it outdoes adalimumab without sacrificing safety in rheumatoid arthritis treatment.



Srinivasan Pillai, MD

Latest:

Depression in the Elderly

Depression is a common problem among elderly patients in primary care clinics and inpatient settings.





Mark P. Jarrett, MD, MBA

Latest:

It Can't Happen Here: Examining the Odds of an Ebola Outbreak in the US

News reports on the first case of Ebola diagnosed in the US have stoked fears that we could be facing an outbreak of the disease. However, experts say that characteristics of the disease itself, plus a robust public health infrastructure, make that highly unlikely.



Lauren Thaxton, MD, MBA

Latest:

Painful Buttock Lesion in a Pregnant Woman

A 36-year-old pregnant woman at 27 weeks gestation presented to the obstetrical triage for evaluation of possible abscess due to a lesion on her buttock that first appeared 1 week ago. Since that time, it has become increasingly painful and itchy. Although she denies any systemic symptoms, her pregnancy is complicated by gestational diabetes and obesity. However, she is HIV negative and her other prenatal labs were unremarkable.



Experimental Medicine, University of Padua Medical School, Padua, Italy.

Latest:

Coronary artery disease in asymptomatic diabetic patients

We evaluated the effectiveness of the current American Diabetes Association guidelines for the detection of coronary artery disease (CAD) in asymptomatic patients with type 2 diabetes and assessed whether a more aggressive diagnostic strategy would permit detection of silent CAD at an earlier stage. The prevalence of myocardial perfusion defects and CAD in asymptomatic diabetic patients was high independent of risk factor profile, and an aggressive diagnostic approach in patients who would normally be excluded from screening permitted identification of CAD at an earlier stage, when coronary anatomy is more likely to respond to treatment.





Jane Luu, MD1

Latest:

Community-acquired MRSA pericarditis

Only 2 cases of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) pericarditis have been reported in the English literature. Over the last 15 years, CA-MRSA has emerged as an increasingly common pathogen that is genetically and epidemiologically different from hospital-acquired MRSA (HA-MRSA).




L. G. Mellbin, MD

Latest:

Glucose-lowering treatment impacts prognosis in diabetic patients after MI: Post hoc analysis of the DIGAMI 2 trial

We conducted a post hoc analysis of the DIGAMI 2 (Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction 2) trial to assess the impact of glucose-lowering treatment in 1181 diabetic patients who were discharged from the hospital after experiencing a myocardial infarction (MI).



Simon Sikorski

Latest:

Transcatheter Valve Replacement - Advancements in Minimally Invasive Cardiac Surgery

Dr. Stewart discusses advancements in cardiac surgery & transcatheter valve replacement therapy.




Glenn van Langenhove, MD, PhD for the DELAYED RRISC (Dea

Latest:

Late mortality with sirolimus-eluting stents in diseased saphenous vein grafts

In a secondary post-hoc analysis of the Reduction of Restenosis in Saphenous Vein Grafts with Cypher (RRISC) trial, we compared the long-term safety of sirolimus-eluting stents (SES) with bare-metal stents (BMS) in diseased saphenous vein grafts


Iltifat Hussain, MD

Latest:

The "iPatient" and the Lost Art of the Physical Exam

Fantastic story from NPR about how some in medicine feel the art of the physical exam is fading in favor of emerging technologies.

© 2024 MJH Life Sciences

All rights reserved.